“Neoadjuvant SEMA4D blockade with nivolumab alters suppressive myeloid cells while elevating B cell and CD26hi T cell infiltration in the tumors of patients with resectable stage III melanoma” presented by Dr. Brian Olson of Emory University
Friday Nov 11, 4:20-5:35

“Phase I Study of Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine and Pepinemab/Trastuzumab in Patients with Metastatic HER2-Positive Breast Cancer (MBC)” poster presentation by Dr. Hyo Han of Moffitt Cancer Center
Nov 10 - 11, 9:00 am - 9:00 pm